Table 2 Positive rates of single and combined tumor markers in early gastric cancer patients
From: Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
Tumor marker | CA19–9 | AFP | CA125 | |
|---|---|---|---|---|
CEA | 25(4.3%) | 48(8.2%) | 31(5.3%) | 35(6.0%) |
CA19–9 | 28(4.8%) | 37(6.3%) | 33(5.6%) | |
AFP | 9(1.5%) | 20(3.4%) | ||
CA125 | 11(1.9%) | |||
CEA + CA19–9 | 55(9.4%) | 55(9.4%) | ||
CEA + AFP | 41(7.0%) | |||
CA19–9 + AFP | 44(7.5%) | |||
CEA + CA19–9 + AFP | 61(10.4%) |